Offer - Urjas Oil for just ₹ 1 X
Rapilif 4 Mg Capsule (10) is a commercial drug that is prescribed in the form of Capsule. Enlarged Prostate are some of its major therapeutic uses.
The optimal dosage of Rapilif 4 Mg Capsule (10) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Rapilif 4 Mg Capsule (10) can also lead to other problems, which have been listed below. These side effects of Rapilif 4 Mg Capsule (10) are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Rapilif 4 Mg Capsule (10) has a Not Used By Women effect for pregnant women and Not Used By Women effect on lactating mothers. In addition, Rapilif 4 Mg Capsule (10)'s effects on the liver, heart and kidney are discussed below in the Rapilif 4 Mg Capsule (10) related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Liver Disease must refrain from the use of Rapilif 4 Mg Capsule (10) since this can cause severe adverse effects. The section on Rapilif 4 Mg Capsule (10) contraindications lists all such conditions.
Additionally, Rapilif 4 Mg Capsule (10) may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rapilif 4 Mg Capsule (10) is considered not safe while driving, and is not addictive.
Rapilif 4 Mg Capsule (10) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rapilif 4 Mg Capsule (10) safe for pregnant women?
Not Used by Women
Is the use of Rapilif 4 Mg Capsule (10) safe during breastfeeding?
Not Used by Women
What is the effect of Rapilif 4 Mg Capsule (10) on the Kidneys?
There can be some harmful effects on your kidneys after taking Rapilif. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Rapilif 4 Mg Capsule (10) on the Liver?
Rapilif may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Rapilif 4 Mg Capsule (10) on the Heart?
Side effects of Rapilif rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Rapilif 4 Mg Capsule (10) unless your doctor advises you to do so -
Is this Rapilif 4 Mg Capsule (10) habit forming or addictive?
No, there is no any evidence that Rapilif 4 Mg Capsule (10) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rapilif 4 Mg Capsule (10) can make you feel drowsy.
Is it safe?
Rapilif 4 Mg Capsule (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Rapilif 4 Mg Capsule (10) is not used to treat mental disorders.
Interaction between Food and Rapilif 4 Mg Capsule (10)
There isn't any research available on the side effects of taking Rapilif 4 Mg Capsule (10) with food.
Interaction between Alcohol and Rapilif 4 Mg Capsule (10)
No research has been done on this till date. Therefore, it is not known what the effect of taking Rapilif 4 Mg Capsule (10) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rapaflo® (silodosin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1137-1138